Skip to Main Content

Examination of Glutamate and mGluR5 in Psychiatric Disorders

Conditions

Diseases of the Nervous System | Mental Health & Behavioral Research

What is the purpose of this trial?

This research study is designed to look at the involvement of the glutamate system in depression. Each subject will undergo a screening appointment to determine study eligibility. Thereafter, the study will take 2 or 3 visits depending on schedule availability and will consist of one MRI scan, and PET scan. Subjects will also participate in cognitive testing. Depending on camera time, staff availability and subject schedule, total study participation may last 1-2 months.

  • Trial with
    Yale University School of Medicine
  • Start Date
    08/22/2011
  • End Date
    08/21/2021
Trial Image

For more information about this study, contact:

Nicole DellaGioia

I'm interested in volunteering

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email helpusdiscover@yale.edu or call 877.978.8348

  • Last Updated
    12/12/2018
  • Study HIC
    #1101007933